4//SEC Filing
ARENA PHARMACEUTICALS INC 4
Accession 0001196862-15-000001
CIK 0001080709operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:58 PM ET
Size
12.5 KB
Accession
0001196862-15-000001
Insider Transaction Report
Form 4
WOODS RANDALL E
Director
Transactions
- Exercise/Conversion
Common Stock
2015-03-30$1.27/sh+36,000$45,720→ 121,380 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-30−40,268→ 12,000 totalExercise: $1.49Exp: 2021-03-15→ Common Stock (40,268 underlying) - Exercise/Conversion
Common Stock
2015-03-30$1.49/sh+40,268$59,999→ 85,380 total - Sale
Common Stock
2015-03-30$4.49/sh−76,268$342,253→ 45,112 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-30−36,000→ 0 totalExercise: $1.27Exp: 2021-06-13→ Common Stock (36,000 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.48 and $4.50 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The options vested in 12 equal monthly installments over one year beginning on April 15, 2011, and became exercisable once vested.
- [F3]The options vested in 12 equal monthly installments over one year beginning on July 13, 2011, and became exercisable once vested.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001080709
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:58 PM ET
- Size
- 12.5 KB